BIOLOGICAL E TO TEST COVID-19 VACCINE CORBEVAX ON INFANTS AS YOUNG AS SIX MONTHS
Biological E ( BE ), a Hyderabad-based vaccine and pharmaceutical company , has recently announced the publication of CORBEVAX COVID-19 vaccine phase II / III clinical trials conducted in paediatric population ( 5 to < 18 age group ). The vaccine has demonstrated excellent safety profile in children and adolescents . The vaccine also demonstrated excellent immunogenicity as measured by humoral and cellular immune responses . In August , CORBEVAX became the first vaccine in India to get DCGI approval for a COVID-19 heterologous booster shot . It can be administered six months after two doses of COVISHIELD or COVAXIN for all adults .
Dr Vikram Paradkar , Executive Vice President-Technical Operations , Biological E . Limited , said , “ CORBEVAX getting approved for our paediatric population from 5 to 18 age-group was a major milestone for us and its subsequent Pan-India deployment for kids of 12-14 years was important in our fight against coronavirus . So far , approximately 74 million doses of CORBEVAX has been administered to kids in India and almost 33 million kids have completed two-dose primary vaccination , which represents one of the largest paediatric campaigns globally ."
STRAND LIFE SCIENCES LAUNCHES ‘ STRAND GENOMIC WELLNESS ’
Strand Life Sciences , a genomics-based research and diagnostics company , has launched ‘ Strand Genomic Wellness ’, a new line of genomic-based tests for preventive wellness . As the first offering of the program , Strand has introduced the ‘ Genomic Health Insight ’ report to help individuals understand how their personal genomic variations might influence their risk for a broad range of diseases with 30-100 % heritability . This knowledge can help individuals work with their doctors to manage their risk with proactive wellness measures .
A recent study published by Mayo Clinic Proceedings indicates that nearly 1 in 8 people who underwent predictive genomic testing found that they had a genetic risk for a health condition and may be able to manage it better with preventive care . Rising adoption of healthier lifestyles and increasing awareness of new healthcare programs and advancements are expected to drive increasing demand for predictive genetic testing .
Commenting on the new launch , Dr . Ramesh Hariharan , CEO & Co-Founder , Strand Life Sciences , said , “ We are excited to bring our 22 years of experience in Genomics and Bioinformatics to help individuals use genomics-based insights to proactively manage their wellness . Genomics is advancing at a breakneck pace , and the Genomic Wellness initiative will bring these advances to the Indian consumer , beginning with inherited insights and eventually covering evolving insights that reflect the dynamic of the ageing body .”
AAKASH HEALTHCARE OPENS MULTI-SPECIALITY HOSPITAL IN TASHKENT
Aakash Healthcare has announced its expansion plans and said it is now all set to foray into a foreign land with the opening of a multi-speciality hospital in Tashkent , Uzbekistan . New Delhi-based hospital becomes the first Indian Hospital to open a fully managed hospital with an initial investment of $ 3.5 million in a foreign land . There are many Indian healthcare players operational in various parts of Uzbekistan , but most are offering OPD and mini-surgeries camps or have limited liability tie-ups with existing local hospitals .
Aakash Healthcare LLC also intends to train local doctors , surgeons , nursing and support staff with quality healthcare practices , so that over a period of time , local healthcare professionals can work at par with their Indian counterparts . The exchange program for the training of Uzbek staff in India is also very much on the cards . The hospital has 50 beds and speciality departments . With a wide spectrum of specialties , including orthopaedics , paediatrics , endocrinology , neurology , internal medicine , physiotherapy , cardiology , gynaecology , urology , general surgery , neurosurgery , ENT , USG , X-ray , Laboratory , Dentistry , Aakash Hospital , Tashken will work according to best global practices with world-class facilities .
HCAH ACQUIRES SENIORITY , EXPANDS ITS PRESENCE IN THE GERIATRIC HEALTH MARKET IN INDIA
Health tech company HCAH ( formerly Health care atHOME ), a major player in the out-of-hospital care segment in India , has announced its acquisition of India ’ s largest geriatric-centric digital platform Seniority . With this , HCAH plans to integrate its existing healthcare services into the company and develop a geriatric-focused vertical to provide end-to-end senior care services for their holistic well-being and requirements . Owned by the RPG Group , Seniority operates India ’ s largest geriatric-focused digital platform . It offers a curated portfolio of over 20,000 products ranging from medical to lifestyle for senior citizens and sells direct to customers . The company also operates two offline stores in Pune and Chennai .
Vivek Srivastava , Co-Founder and CEO , HCAH , said , “ We believe that the growth in the elderly markets is a secular trend that would continue for the next many decades . Besides growing the digital business , as a part of our Phygital strategy , we would also open new stores of Seniority on a standalone basis as well as in our transition care centers . We will launch new services such as Assisted Living , Elderly day care and Elderly Concierge services in the future to further solidify our presence in the elderly market .”
GEORGE INSTITUTE & IMPERIAL COLLEGE , LONDON TO ESTABLISH CENTRE ON NON-COMMUNICABLE DISEASES & ENVIRONMENTAL CHANGE
The George Institute for Global Health , India and Imperial College London has announced the establishment of NIHR Global Health Research Centre on Non-Communicable Diseases and Environmental Change . The Centre will work to tackle the dual challenges of a rapidly growing burden of Non-
BIOVOICENEWS . COM 11